Sign in
4

Changes in Ownership

Editas Medicine, Inc. Filed Acc 0001415889-23-007990

EVP, CHIEF FINANCIAL OFFICER sold 949 shares at $9.87 ($9,369)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
ROBERTSON MICHELLE EVP, CHIEF FINANCIAL OFFICER 2023-05-11 Sale 10b5-1 −949 $9.87 $9,369 106,610 D
Open-market sales · 949 sh · avg $9.87 · $9,369
Loading xslF345X04/form4-05152023_040503.xml…